{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:41:18Z","timestamp":1791499278313,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jtct.2023.02.020","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T12:49:55Z","timestamp":1677415795000},"page":"362.e1-362.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-6493","authenticated-orcid":false,"given":"El\u00e9onore","family":"Kaphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Bettega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Labussi\u00e8re-Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Fegueux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault De Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9opoldine","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berceanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambroise","family":"Marcais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-4278","authenticated-orcid":false,"given":"Pierre-Edouard","family":"Debureaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vanlangendonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-7431","authenticated-orcid":false,"given":"Claude-Eric","family":"Bulabois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lioure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Antier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-5939","authenticated-orcid":false,"given":"Michael","family":"Loschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Mear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2252","authenticated-orcid":false,"given":"Sylvain","family":"Chantepie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Poire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Contentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Orvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5024-1713","authenticated-orcid":false,"given":"R\u00e9my","family":"Dulery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2957","authenticated-orcid":false,"given":"Carolyne","family":"Croizier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4650-7520","authenticated-orcid":false,"given":"Yves","family":"Beguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Skrzypczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Desmier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Carr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thiebaut-Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.02.020_bib0001","doi-asserted-by":"crossref","first-page":"454\u2011459","DOI":"10.1016\/j.bbmt.2014.11.007","article-title":"Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a Center for International Blood and Marrow Transplant Research study","volume":"21","author":"Bejanyan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0002","doi-asserted-by":"crossref","first-page":"82\u201189","DOI":"10.1111\/bjh.14965","article-title":"Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003\/2007 trial","volume":"180","author":"Kuhlen","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0003","doi-asserted-by":"crossref","first-page":"1599\u20111606","DOI":"10.1182\/blood-2011-08-375840","article-title":"Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation","volume":"119","author":"Schmid","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0004","doi-asserted-by":"crossref","first-page":"547\u2011554","DOI":"10.1002\/cncr.21187","article-title":"Outcome of patients with acute myelogenous leukemia after second salvage therapy","volume":"104","author":"Giles","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.02.020_bib0005","doi-asserted-by":"crossref","first-page":"232\u2011238","DOI":"10.1200\/JCO.1988.6.2.232","article-title":"The characteristics and outcome of patients with late relapse acute myelogenous leukemia","volume":"6","author":"Kantarjian","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0006","doi-asserted-by":"crossref","first-page":"1211\u20111217","DOI":"10.1038\/leu.2011.351","article-title":"Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT","volume":"26","author":"Spyridonidis","year":"2012","journal-title":"Leukemia."},{"key":"10.1016\/j.jtct.2023.02.020_bib0007","doi-asserted-by":"crossref","first-page":"2230\u20112239","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0008","doi-asserted-by":"crossref","first-page":"14\u201121","DOI":"10.1056\/NEJM199907013410103","article-title":"Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry","volume":"341","author":"Soci\u00e9","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.02.020_bib0009","doi-asserted-by":"crossref","first-page":"424\u2011447","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0010","doi-asserted-by":"crossref","first-page":"2753\u20112767","DOI":"10.1182\/blood.2021013626","article-title":"2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0011","doi-asserted-by":"crossref","first-page":"3996\u20114009","DOI":"10.1182\/blood-2015-03-580027","article-title":"Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies","volume":"125","author":"van Dongen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0012","first-page":"825\u2011828","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0014","doi-asserted-by":"crossref","first-page":"1713\u20111718","DOI":"10.1016\/j.bbmt.2013.09.011","article-title":"Outcome and prognostic factors for patients who relapse after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Thanarajasingam","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0015","doi-asserted-by":"crossref","first-page":"100\u2011106","DOI":"10.1016\/j.bbmt.2018.08.012","article-title":"Kinetics and risk factors of relapse after allogeneic stem cell transplantation in children with leukemia: a long-term follow-up single-center study","volume":"25","author":"Molina","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0016","doi-asserted-by":"crossref","first-page":"1316\u20111324","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.11.013","article-title":"Graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide versus cyclosporine A and methotrexate in matched sibling donor transplantation","volume":"28","author":"Nagler","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.02.020_bib0018","doi-asserted-by":"crossref","first-page":"276\u2011285","DOI":"10.1111\/imj.13522","article-title":"Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse","volume":"48","author":"Lim","year":"2018","journal-title":"Intern Med J."},{"key":"10.1016\/j.jtct.2023.02.020_bib0019","doi-asserted-by":"crossref","first-page":"2008\u20112016","DOI":"10.1038\/s41409-020-0868-7","article-title":"Long-term results of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia: a retrospective analysis of 10-year follow-up data","volume":"55","author":"Yanada","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0020","doi-asserted-by":"crossref","first-page":"589\u2011596","DOI":"10.3324\/haematol.2009.014274","article-title":"Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group","volume":"95","author":"Oriol","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.02.020_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41408-021-00516-1","article-title":"Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomes","volume":"11","author":"Aldoss","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.02.020_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-019-0170-3","article-title":"Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?","volume":"9","author":"Yilmaz","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.02.020_bib0023","doi-asserted-by":"crossref","first-page":"778\u2011782","DOI":"10.3109\/10428191003661852","article-title":"Late relapses in acute myeloid leukemia: analysis of characteristics and outcome","volume":"51","author":"Verma","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.02.020_bib0024","doi-asserted-by":"crossref","first-page":"65\u201171","DOI":"10.1080\/10428190601043252","article-title":"Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)","volume":"48","author":"Medeiros","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.02.020_bib0025","doi-asserted-by":"crossref","first-page":"811\u2011814","DOI":"10.3727\/096504020X15965357399750","article-title":"Outcomes of patients with acute myeloid leukemia who relapse after 5 years of complete remission","volume":"28","author":"Patel","year":"2021","journal-title":"Oncol Res"},{"key":"10.1016\/j.jtct.2023.02.020_bib0026","first-page":"427\u2011434","article-title":"Outcome of very late relapse in children with acute lymphoblastic leukemia","volume":"89","author":"Rizzari","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.02.020_bib0027","doi-asserted-by":"crossref","first-page":"37\u201143","DOI":"10.1111\/bjh.16616","article-title":"At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII\/ECOG E2993 trial","volume":"191","author":"Ganzel","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0028","doi-asserted-by":"crossref","first-page":"179\u2011184","DOI":"10.3324\/haematol.2012.073189","article-title":"Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"98","author":"Harris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.02.020_bib0029","doi-asserted-by":"crossref","first-page":"835\u2011842","DOI":"10.1038\/sj.bmt.1704223","article-title":"Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course","volume":"32","author":"Lee","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0030","doi-asserted-by":"crossref","first-page":"860\u2011863","DOI":"10.3324\/haematol.2010.025890","article-title":"Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome","volume":"95","author":"Clark","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2023.02.020_bib0031","doi-asserted-by":"crossref","first-page":"1087\u20111094","DOI":"10.1016\/j.bbmt.2017.03.023","article-title":"Isolated extramedullary relapse of acute leukemia after allogeneic stem cell transplantation: different kinetics and better prognosis than systemic relapse","volume":"23","author":"Shem-Tov","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0032","doi-asserted-by":"crossref","first-page":"1040\u20111047","DOI":"10.1016\/j.bbmt.2014.03.030","article-title":"Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia","volume":"20","author":"Ge","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0033","doi-asserted-by":"crossref","first-page":"143\u2011154","DOI":"10.1016\/j.immuni.2015.12.008","article-title":"The PD-1 axis enforces an anatomical segregation of CTL activity that creates tumor niches after allogeneic hematopoietic stem cell transplantation","volume":"44","author":"Michonneau","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2023.02.020_bib0034","doi-asserted-by":"crossref","first-page":"177\u2011188","DOI":"10.1182\/bloodadvances.2017011510","article-title":"Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy","volume":"2","author":"Spinella","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.02.020_bib0035","doi-asserted-by":"crossref","first-page":"193\u2011204","DOI":"10.1182\/bloodadvances.2016000760","article-title":"Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia","volume":"1","author":"Quek","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.02.020_bib0036","doi-asserted-by":"crossref","first-page":"3093\u20113104","DOI":"10.1182\/blood.2020007626","article-title":"Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin","volume":"137","author":"Schmalbrock","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0037","doi-asserted-by":"crossref","first-page":"934\u2011946","DOI":"10.1200\/JCO.2016.71.2208","article-title":"Genomics of acute myeloid leukemia diagnosis and pathways","volume":"35","author":"Bullinger","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0038","doi-asserted-by":"crossref","first-page":"264\u2011278","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jtct.2023.02.020_bib0039","doi-asserted-by":"crossref","first-page":"247\u2011262","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.02.020_bib0040","doi-asserted-by":"crossref","first-page":"352\u2011364","DOI":"10.1182\/bloodadvances.2020003005","article-title":"Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide","volume":"5","author":"Rambaldi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.02.020_bib0041","first-page":"1229\u20111235","article-title":"Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation","volume":"27","author":"Schroeder","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2023.02.020_bib0042","first-page":"4938\u20114945","volume":"25","author":"Schmid","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0043","doi-asserted-by":"crossref","first-page":"1508\u20111512","DOI":"10.1038\/bmt.2015.193","article-title":"Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of \u226510 years","volume":"50","author":"Andreola","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0044","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41408-019-0251-3","article-title":"Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT","volume":"9","author":"Shimoni","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.02.020_bib0045","doi-asserted-by":"crossref","first-page":"769\u2011777","DOI":"10.1038\/bmt.2009.300","article-title":"Management of relapse after allo-SCT for AML and the role of second transplantation","volume":"44","author":"Savani","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0046","doi-asserted-by":"crossref","first-page":"186\u2011193","DOI":"10.1038\/bmt.2015.221","article-title":"Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes","volume":"51","author":"Vrhovac","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0047","doi-asserted-by":"crossref","first-page":"3675\u20113684","DOI":"10.1200\/JCO.2001.19.16.3675","article-title":"Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation","volume":"19","author":"Bosi","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0048","doi-asserted-by":"crossref","first-page":"3259\u20113271","DOI":"10.1200\/JCO.2012.44.7961","article-title":"Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change","volume":"31","author":"Christopeit","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0049","doi-asserted-by":"crossref","first-page":"157\u2011162","DOI":"10.1038\/sj.bmt.1705011","article-title":"Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia","volume":"36","author":"Hosing","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0050","doi-asserted-by":"crossref","first-page":"235\u2011240","DOI":"10.1016\/j.bbmt.2011.06.010","article-title":"EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedure","volume":"18","author":"Rezvani","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.02.020_bib0051","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exphem.2018.03.002","article-title":"Analysis of relapse after transplantation in acute leukemia: a comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions","volume":"62","author":"Ort\u00ed","year":"2018","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0052","doi-asserted-by":"crossref","first-page":"1201\u20111212","DOI":"10.1016\/S1470-2045(20)30455-1","article-title":"Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial","volume":"21","author":"Xuan","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0053","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41571-020-00431-7","article-title":"Sorafenib prevents AML relapse after allo-HSCT","volume":"17","author":"Romero","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0054","doi-asserted-by":"crossref","first-page":"767\u2011776","DOI":"10.1111\/bjh.15973","article-title":"Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation","volume":"186","author":"Nagler","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2023.02.020_bib0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.2021015328","article-title":"Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study","volume":"140","author":"Duployez","year":"2022","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:10:21Z","timestamp":1763003421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723011296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666636723011296"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.02.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}